PUBLIC LAW 110–85—SEPT. 27, 2007
121 STAT. 891
‘‘Subchapter I—Reagan-Udall Foundation for the Food and Drug Administration ‘‘SEC. 770. ESTABLISHMENT AND FUNCTIONS OF THE FOUNDATION.
dkrause on GSDDPC44 with PUBLAW
‘‘(a) IN GENERAL.—A nonprofit corporation to be known as the Reagan-Udall Foundation for the Food and Drug Administration (referred to in this subchapter as the ‘Foundation’) shall be established in accordance with this section. The Foundation shall be headed by an Executive Director, appointed by the members of the Board of Directors under subsection (e). The Foundation shall not be an agency or instrumentality of the United States Government. ‘‘(b) PURPOSE OF FOUNDATION.—The purpose of the Foundation is to advance the mission of the Food and Drug Administration to modernize medical, veterinary, food, food ingredient, and cosmetic product development, accelerate innovation, and enhance product safety. ‘‘(c) DUTIES OF THE FOUNDATION.—The Foundation shall— ‘‘(1) taking into consideration the Critical Path reports and priorities published by the Food and Drug Administration, identify unmet needs in the development, manufacture, and evaluation of the safety and effectiveness, including postapproval, of devices, including diagnostics, biologics, and drugs, and the safety of food, food ingredients, and cosmetics, and including the incorporation of more sensitive and predictive tools and devices to measure safety; ‘‘(2) establish goals and priorities in order to meet the unmet needs identified in paragraph (1); ‘‘(3) in consultation with the Secretary, identify existing and proposed Federal intramural and extramural research and development programs relating to the goals and priorities established under paragraph (2), coordinate Foundation activities with such programs, and minimize Foundation duplication of existing efforts; ‘‘(4) award grants to, or enter into contracts, memoranda of understanding, or cooperative agreements with, scientists and entities, which may include the Food and Drug Administration, university consortia, public-private partnerships, institutions of higher education, entities described in section 501(c)(3) of the Internal Revenue Code (and exempt from tax under section 501(a) of such Code), and industry, to efficiently and effectively advance the goals and priorities established under paragraph (2); ‘‘(5) recruit meeting participants and hold or sponsor (in whole or in part) meetings as appropriate to further the goals and priorities established under paragraph (2); ‘‘(6) release and publish information and data and, to the extent practicable, license, distribute, and release material, reagents, and techniques to maximize, promote, and coordinate the availability of such material, reagents, and techniques for use by the Food and Drug Administration, nonprofit organizations, and academic and industrial researchers to further the goals and priorities established under paragraph (2); ‘‘(7) ensure that— ‘‘(A) action is taken as necessary to obtain patents for inventions developed by the Foundation or with funds from the Foundation;
VerDate Aug 31 2005
13:52 Jan 23, 2009
Jkt 059194
PO 00001
Frm 00889
Fmt 6580
Sfmt 6581
21 USC 379dd.
Grants. Contracts. Memorandums.
Publication.
M:\STATUTES\2007\59194PT1.001
APPS10
PsN: 59194PT1
�
